‚ÄčNaschitz Brandes Amir Represents Israel Biotech Fund as the Lead Investor in a $30 million Financing Round in Pharma Two B Ltd.

Naschitz Brandes Amir Represented Israeli Biotech Fund, a venture capital fund specializing in investments in biotech companies, as the lead investor in a $30 million financing round in Pharma Two B Ltd., a company developing clinically differentiated and value-added products, based on approved drugs. The transaction was finalized in February 2017.

Israel Biotech Fund was represented by partner Anat Igner and associate Idit Zimmerman.